CHMP

News

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Roche's Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending the treatment options for people with the life-threatenin

News

scientifically visualization of a coronavirus spike protein

CHMP backs Celltrion's regdanvimab antibody for COVID-19

The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human medicines committee backed use of Celltrion's regdanvimab at its March meeting. <

News

J&J’s COVID-19 shot backed for emergency use in EU

The EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot from Johnson & Johnson’s Janssen unit – after a review by it

News

EMA backs emergency use of Lilly’s COVID antibodies

The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who are at risk of developing severe disease, clearing the way for use in EU memb

News

CHMP clears way for EU approval of Novartis' MS drug

Novartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, paving the way for a likely approval in the coming weeks.

News

The unprecedented challenge of pricing a coronavirus vaccine

EMA approves AZ’s COVID-19 vaccine – including for over-65s

The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18, despite assertions in Germany this week that it shouldn’t be used in elderly people.

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

CHMP backs Celltrion's regdanvimab antibody for COVID-19

J&J’s COVID-19 shot backed for emergency use in EU

EMA backs emergency use of Lilly’s COVID antibodies

CHMP clears way for EU approval of Novartis' MS drug

EMA approves AZ’s COVID-19 vaccine – including for over-65s

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

CHMP

Editor's Picks